—

Fresenius Medical Care Corporation(FMS)— 同業公司組

數據截至2026-10-12 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Fresenius Medical Care Corporation的Closelook綜合評分為50/100,在同業公司組內排名第6位(共8家)——組內評分最高的是Halozyme Therapeutics Inc(74/100)。

名稱綜合動能品質估值訊號距52週高點
FMS Fresenius Medical Care Corporation50353484info19.9%
PACS PACS Group, Inc.54723953ok10.5%
ENSG The Ensign Group Inc48403443warn20.2%
RHC.AU Ramsay Health Care Ltd45892252ok3.4%
HALO Halozyme Therapeutics Inc74949448ok4.9%
DXCM DexCom Inc66858035bull9.2%
ONC BeiGene, Ltd.63766230info9%
MEDP Medpace Holdings Inc63857428ok8.5%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-12

Quick answers

Fresenius Medical Care Corporation在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:PACS Group, Inc. (PACS)、The Ensign Group Inc (ENSG)、Ramsay Health Care Ltd (RHC.AU)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)、BeiGene, Ltd. (ONC)、Medpace Holdings Inc (MEDP)。

FMS相對同業公司的評分如何?

Fresenius Medical Care Corporation的綜合評分為50/100,組內排名第6位(共8家),截至2026-10-12;組內最高綜合評分為Halozyme Therapeutics Inc(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.